Portfolio (Quarterly)
Guide ↗
ADAR1 Capital Management, LLC
· CIK 0001940272| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ABVX | ABIVAX SA | Healthcare | 1,394,019.0 | $155.2M | 9.14% | NEW | — | $111.35 | +2.1% |
| 2 | PTGX | PROTAGONIST THERAPEUTICS INC | Healthcare | 994,119.0 | $104.8M | 6.17% | NEW | — | $105.40 | -4.4% |
| 3 | ROIV | ROIVANT SCIENCES LTD | Healthcare | 3,285,906.0 | $91.0M | 5.36% | NEW | — | $27.70 | +3.1% |
| 4 | IMVT | IMMUNOVANT INC | Healthcare | 2,679,010.0 | $66.5M | 3.92% | NEW | — | $24.84 | +6.8% |
| 5 | SPY | STATE STR SPDR S&P 500 ETF T | Financial Services | 75,940.0 | $49.4M | 2.91% | NEW | — | $650.34 | +12.8% |
| 6 | TERN | TERNS PHARMACEUTICALS INC | Healthcare | 914,699.0 | $48.2M | 2.84% | NEW | — | $52.72 | +0.4% |
| 7 | CYTK | CYTOKINETICS INC | Healthcare | 632,556.0 | $41.7M | 2.45% | NEW | — | $65.91 | +14.1% |
| 8 | CRNX | CRINETICS PHARMACEUTICALS IN | Healthcare | 1,139,331.0 | $41.4M | 2.44% | NEW | — | $36.32 | -4.5% |
| 9 | BOXX | EA SERIES TRUST | — | 337,125.0 | $39.2M | 2.31% | NEW | — | $116.29 | +0.4% |
| 10 | DNLI | DENALI THERAPEUTICS INC | Healthcare | 1,871,455.0 | $35.9M | 2.12% | NEW | — | $19.20 | -4.2% |
| 11 | BEAM | BEAM THERAPEUTICS INC | Healthcare | 1,446,375.0 | $34.5M | 2.03% | NEW | — | $23.83 | +10.5% |
| 12 | ZLAB | ZAI LAB LTD | Healthcare | 1,425,367.0 | $26.8M | 1.58% | NEW | — | $18.81 | +0.3% |
| 13 | SEPN | SEPTERNA INC | Healthcare | 1,089,818.0 | $26.2M | 1.54% | NEW | — | $24.03 | +9.4% |
| 14 | VIR | VIR BIOTECHNOLOGY INC | Healthcare | 2,744,714.0 | $24.6M | 1.45% | NEW | — | $8.96 | -2.1% |
| 15 | — | DBV TECHNOLOGIES S A | — | 1,012,866.0 | $21.2M | 1.25% | NEW | — | $20.89 | — |
| 16 | — | ANTERIS TECHNOLOGIES GLOBAL | — | 3,789,132.0 | $21.0M | 1.24% | NEW | — | $5.55 | — |
| 17 | INSP | INSPIRE MED SYS INC | Healthcare | 405,197.0 | $20.9M | 1.23% | NEW | — | $51.58 | -18.9% |
| 18 | SRRK | SCHOLAR ROCK HLDG CORP | Healthcare | 407,273.0 | $20.0M | 1.18% | NEW | — | $49.16 | -3.6% |
| 19 | RYTM | RHYTHM PHARMACEUTICALS INC | Healthcare | 211,450.0 | $18.4M | 1.08% | NEW | — | $86.97 | -0.1% |
| 20 | SYRE | SPYRE THERAPEUTICS INC | Healthcare | 338,323.0 | $17.1M | 1.00% | NEW | — | $50.44 | +38.9% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
94.6%
Financial Services
4.9%
Real Estate
0.1%
Consumer Cyclical
0.1%
Technology
0.1%
Communication Services
0.1%
Industrials
0.1%
Basic Materials
0.1%